{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:30:49Z","timestamp":1783575049645,"version":"3.55.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Despite the availability of advanced technology to detect and treat esophageal squamous cell carcinoma (ESCC), the 5-year survival rate of ESCC patients is still meager. Recently, long non-coding RNAs (lncRNAs) have emerged as essential players in the diagnosis and prognosis of various cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This pilot study focused on identifying circulating lncRNAs as liquid biopsy markers for the ESCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>We performed next-generation sequencing (NGS) to profile circulating lncRNAs in ESCC and healthy individuals\u2019 blood samples. The expression of the top five upregulated and top five downregulated lncRNAs were validated through quantitative real-time PCR (qRT-PCR), including samples used for the NGS. Later, we explored the diagnostic\/prognostic potential of lncRNAs and their impact on the clinicopathological parameters of patients. To unravel the molecular target and pathways of identified lncRNAs, we utilized various bioinformatics tools such as lncRnome, RAID v2.0, Starbase, miRDB, TargetScan, Gene Ontology, and KEGG pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Through NGS profiling, we obtained 159 upregulated, 137 downregulated, and 188 neutral lncRNAs in ESCC blood samples compared to healthy individuals. Among dysregulated lncRNAs, we observed <jats:italic>LINC00324 significantly upregulated<\/jats:italic> (2.11-fold; <jats:italic>p-value<\/jats:italic> = 0.0032) and <jats:italic>LOC100507053<\/jats:italic> significantly downregulated (2.22-fold; <jats:italic>p-value<\/jats:italic> = 0.0001) in ESCC patients. Furthermore, we found <jats:italic>LINC00324<\/jats:italic> and <jats:italic>LOC100507053<\/jats:italic> could discriminate ESCC cancer patients\u2019 from non-cancer individuals with higher accuracy of Area Under the ROC Curve (AUC) = 0.627 and 0.668, respectively. The Kaplan-Meier and log-rank analysis revealed higher expression levels of <jats:italic>LINC00324<\/jats:italic> and lower expression levels of <jats:italic>LOC100507053<\/jats:italic> well correlated with the poor prognosis of ESCC patients with a Hazard ratio of <jats:italic>LINC00324<\/jats:italic> = 2.48 (95% CI: 1.055 to 5.835) and Hazard ratio of <jats:italic>LOC100507053<\/jats:italic> = 4.75 (95% CI: 2.098 to 10.76)]. Moreover, we also observed lncRNAs expression well correlated with the age (&amp;gt;50 years), gender (Female), alcohol, tobacco, and hot beverages consumers. Using bioinformatics tools, we saw miR-493-5p as the direct molecular target of <jats:italic>LINC00324<\/jats:italic> and interacted with the MAPK signaling pathway in ESCC pathogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This pilot study suggests that circulating <jats:italic>LINC00324<\/jats:italic> and <jats:italic>LOC100507053<\/jats:italic> can be used as a liquid biopsy marker of ESCC; however, multicentric studies are still warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.823953","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T06:04:02Z","timestamp":1644818642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Uttam","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar Singh","family":"Barwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit Kaur","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit Pal Singh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aklank","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937","article-title":"Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e15788","DOI":"10.7759\/cureus.15788","article-title":"Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India","volume":"13","author":"Rana","year":"2021","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer Statistic","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S166078","article-title":"Global Time Trends in the Incidence of Esophageal Squamous Cell Carcinoma","volume":"10","author":"Wang","year":"2018","journal-title":"Clin Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0116951","DOI":"10.1371\/journal.pone.0116951","article-title":"Diagnostic Value of Multiple Tumor Markers for Patients With Esophageal Carcinoma","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22362","article-title":"Long non-Coding RNA: A New Paradigm for Lung Cancer","volume":"54","author":"Khandelwal","year":"2015","journal-title":"Mol Carcinog"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00901","article-title":"SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer","volume":"9","author":"Tamang","year":"2019","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100774","DOI":"10.1016\/j.tranon.2020.100774","article-title":"Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment","volume":"13","author":"Sharma","year":"2020","journal-title":"Transl Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00814","article-title":"Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-Analysis","volume":"8","author":"Gao","year":"2017","journal-title":"Front Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"118035","DOI":"10.1016\/j.lfs.2020.118035","article-title":"Long Non-Coding RNA TINCR as Potential Biomarker and Therapeutic Target for Cancer","volume":"257","author":"Sharma","year":"2020","journal-title":"Life Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.biochi.2020.06.012","article-title":"A Panel of Circulating Long non-Coding RNAs as Liquid Biopsy Biomarkers for Breast and Cervical Cancers","volume":"176","author":"Barwal","year":"2020","journal-title":"Biochimie"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6787","DOI":"10.3390\/ijms21186787","article-title":"Long Non-Coding RNAs as Strategic Molecules to Augment the Radiation Therapy in Esophageal Squamous Cell Carcinoma","volume":"21","author":"Sharma","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-015-0358-5","article-title":"Next-Generation Sequencing Reveals Novel Differentially Regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in Pancreatic Cancer","volume":"14","author":"Muller","year":"2015","journal-title":"Mol Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4981","article-title":"Next Generation Deep Sequencing Identified a Novel lncRNA N375709 Associated With Paclitaxel Resistance in Nasopharyngeal Carcinoma","volume":"36","author":"Ren","year":"2016","journal-title":"Oncol Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S97664","article-title":"Expression Profile Analysis of Long Noncoding RNA in HER-2-Enriched Subtype Breast Cancer by Next-Generation Sequencing and Bioinformatics","volume":"9","author":"Yang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000485344","article-title":"Differential Expression Profiles of the Transcriptome in Breast Cancer Cell Lines Revealed by Next Generation Sequencing","volume":"44","author":"Shi","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.07.041","article-title":"Transcriptomic Analysis of High-Throughput Sequencing About circRNA, lncRNA and mRNA in Bladder Cancer","volume":"677","author":"Li","year":"2018","journal-title":"Gene"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8889","article-title":"Identification of Differential Expression lncRNAs in Gastric Cancer Using Transcriptome Sequencing and Bioinformatics Analyses","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2004","article-title":"Long Noncoding RNA and mRNA Profiling in Cetuximab-Resistant Colorectal Cancer Cells by RNA Sequencing Analysis","volume":"8","author":"Jing","year":"2019","journal-title":"Cancer Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14516","article-title":"RNA Sequencing of Plasma Exosomes Revealed Novel Functional Long Noncoding RNAs in Hepatocellular Carcinoma","volume":"111","author":"Huang","year":"2020","journal-title":"Cancer Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/diagnostics10040228","article-title":"Identification of the Potential Prognostic Markers From the miRNA-lncRNA-mRNA Interactions for Metastatic Renal Cancer via Next-Generation Sequencing and Bioinformatics","volume":"10","author":"Yeh","year":"2020","journal-title":"Diagn (Basel)"},{"key":"B22","volume-title":"FastQC: A Quality Control Tool for High Throughput Sequence Data","author":"Andrews","year":"2010"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt Removes Adapter Sequences From High-Throughput Sequencing Reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923","article-title":"Fast Gapped-Read Alignment With Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: An Integrated Web Application for Differential Expression and Pathway Analysis of RNA-Seq Data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinf"},{"key":"B26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2020.12.026","article-title":"LncRNA ZFAS1 Inhibits Triple-Negative Breast Cancer by Targeting STAT3","volume":"182","author":"Sharma","year":"2021","journal-title":"Biochimie"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bat034","article-title":"Lncrnome: A Comprehensive Knowledgebase of Human Long Noncoding RNAs","volume":"2013","author":"Bhartiya","year":"2013","journal-title":"Database (Oxford)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1052","article-title":"RAID V2.0: An Updated Resource of RNA-Associated Interactions Across Organisms","volume":"45","author":"Yi","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1248","article-title":"Starbase V2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and Protein-RNA Interaction Networks From Large-Scale CLIP-Seq Data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1104","article-title":"miRDB: An Online Resource for microRNA Target Prediction and Functional Annotations","volume":"43","author":"Wong","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","article-title":"Predicting Effective microRNA Target Sites in Mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1014","article-title":"COXPRESdb: A Database of Comparative Gene Coexpression Networks of Eleven Species for Mammals","volume":"41","author":"Obayashi","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i15.1708","article-title":"Blood-Based Biomarkers for Early Detection of Esophageal Squamous Cell Carcinoma","volume":"26","author":"Chu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0032","article-title":"Decoding the LncRNA Transcriptome of Esophageal Cancer: Identification of Clinically Relevant LncRNAs","volume":"12","author":"Khadirnaikar","year":"2018","journal-title":"biomark Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5227-3","article-title":"Transcriptome Profiling of lncRNA and Co-Expression Networks in Esophageal Squamous Cell Carcinoma by RNA Sequencing","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i34.5598","article-title":"Epidemiology of Esophageal Cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1010428317705760","DOI":"10.1177\/1010428317705760","article-title":"Molecular Interplay of Pro-Inflammatory Transcription Factors and non-Coding RNAs in Esophageal Squamous Cell Carcinoma","volume":"39","author":"Sundaram","year":"2017","journal-title":"Tumour Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of Esophageal Squamous Cell Carcinoma","volume":"154","author":"Abnet","year":"2018","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-018-0758-8","article-title":"Long Intergenic non-Coding RNA 00324 Promotes Gastric Cancer Cell Proliferation via Binding With HuR and Stabilizing FAM83B Expression","volume":"9","author":"Zou","year":"2018","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201912_19775","article-title":"Knockdown of Long non-Coding RNA LINC00324 Inhibits Proliferation, Migration and Invasion of Colorectal Cancer Cell via Targeting miR-214-3p","volume":"23","author":"Ni","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103075","article-title":"Long Noncoding RNA LINC00324 Promotes Retinoblastoma Progression by Acting as a Competing Endogenous RNA for microRNA-769-5p, Thereby Increasing STAT3 Expression","volume":"12","author":"Dong","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103021","article-title":"Long Intergenic non-Protein Coding RNA 324 Prevents Breast Cancer Progression by Modulating miR-10b-5p","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4159298","DOI":"10.1155\/2020\/4159298","article-title":"Silencing of Long Noncoding RNA LINC00324 Interacts With MicroRNA-3200-5p to Attenuate the Tumorigenesis of Gastric Cancer via Regulating Bcat1","volume":"2020","author":"Wang","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28973","article-title":"LINC00324 Accelerates the Proliferation and Migration of Osteosarcoma Through Regulating WDR66","volume":"235","author":"Wu","year":"2020","journal-title":"J Cell Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e22692","DOI":"10.1002\/jcla.22692","article-title":"Global Expression Profiling of Metabolic Pathway-Related lncRNAs in Human Gastric Cancer and the Identification of RP11-555H23.1 as a New Diagnostic Biomarker","volume":"33","author":"Mo","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201812_16531","article-title":"LINC00324 Exerts Tumor-Promoting Functions in Lung Adenocarcinoma via Targeting miR-615-5p\/AKT1 Axis","volume":"22","author":"Pan","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11010-020-03819-2","article-title":"LINC00324 Affects Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Regulation of the miR-139-5p\/IGF1R Axis","volume":"473","author":"Zhang","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-018-0663-8","article-title":"Long non-Coding RNAs in Esophageal Cancer: Molecular Mechanisms, Functions, and Potential Applications","volume":"11","author":"Su","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1912126116","article-title":"HERES, a lncRNA That Regulates Canonical and Noncanonical Wnt Signaling Pathways via Interaction With EZH2","volume":"116","author":"You","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46078","article-title":"Regulation of Hippo\/YAP Signaling and Esophageal Squamous Carcinoma Progression by an E3 Ubiquitin Ligase PARK2","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14122","article-title":"Control of Cell Death and Mitochondrial Fission by ERK1\/2 MAP Kinase Signalling","volume":"284","author":"Cook","year":"2017","journal-title":"FEBS J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2297-8","article-title":"Negative Feedback Regulation of the ERK1\/2 MAPK Pathway","volume":"73","author":"Lake","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-3233-2_26","article-title":"Roles of RUNX in Hippo Pathway Signaling","volume":"962","author":"Passaniti","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.7150\/thno.40889","article-title":"A Combat With the YAP\/TAZ-TEAD Oncoproteins for Cancer Therapy","volume":"10","author":"Pobbati","year":"2020","journal-title":"Theranostics"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00079","article-title":"Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect","volume":"6","author":"Wiese","year":"2018","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.823953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T06:04:08Z","timestamp":1644818648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.823953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":56,"alternative-id":["10.3389\/fonc.2022.823953"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.823953","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"article-number":"823953"}}